Form 4: Encompass Health CEO Mark Tarr Sells Shares to Cover Tax Obligations

Encompass Health CEO Mark Tarr sold 31,609 shares of company stock on January 1, 2025, to cover tax obligations related to vesting restricted stock.

Summary

• Mark Tarr, the President and CEO of Encompass Health Corp, sold 31,609 shares of Encompass Health common stock on January 1, 2025.
• The sale was executed at a price of $92.35 per share.
• This transaction was to cover tax withholding obligations incurred from the vesting of restricted stock.
• Following the transaction, Mr. Tarr directly owns 522,489 shares of Encompass Health common stock.

Sentiment

Score: 5

Explanation: The document reflects a routine transaction for tax purposes, not indicative of positive or negative sentiment towards the company's performance.

Industry Context

This is a routine transaction for executives who receive stock-based compensation. It is common for executives to sell shares to cover tax obligations when restricted stock vests.

Comparison to Industry Standards

• Executive stock sales to cover tax obligations are a common practice across publicly traded companies.
• The number of shares sold and the price are specific to Encompass Health and Mark Tarr's compensation package.
• Similar transactions can be observed in other healthcare companies with stock-based compensation plans.

Stakeholder Impact

• The transaction has a minimal impact on shareholders as it is a routine sale to cover tax obligations.
• The sale does not indicate any change in the executive's confidence in the company.

Key Dates

Keywords

Encompass Health, Mark Tarr, stock sale, insider trading, tax obligations, restricted stock, CEO, EHC